PTP1B inhibitors (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePTP1B inhibitors (Abbott)
Drug Alias NameA-119505A-321842A-350676A-366901A-20435 +[12] 
ClassificationSmall molecules
Mechanisms of ActionInsulin sensitizersProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A